vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $57.7M, roughly 1.4× Third Coast Bancshares, Inc.). Third Coast Bancshares, Inc. runs the higher net margin — 28.4% vs -38.1%, a 66.4% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.5%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.

PRCT vs TCBX — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$57.7M
TCBX
Higher net margin
TCBX
TCBX
66.4% more per $
TCBX
28.4%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
17.5%
TCBX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRCT
PRCT
TCBX
TCBX
Revenue
$83.1M
$57.7M
Net Profit
$-31.6M
$16.4M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
28.4%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
20.5%
EPS (diluted)
$-0.56
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TCBX
TCBX
Q1 26
$83.1M
$57.7M
Q4 25
$76.4M
$56.5M
Q3 25
$83.3M
$54.5M
Q2 25
$79.2M
$52.0M
Q1 25
$69.2M
$45.9M
Q4 24
$68.2M
$46.3M
Q3 24
$58.4M
$42.9M
Q2 24
$53.4M
$41.7M
Net Profit
PRCT
PRCT
TCBX
TCBX
Q1 26
$-31.6M
$16.4M
Q4 25
$-29.8M
$17.9M
Q3 25
$-21.4M
$18.1M
Q2 25
$-19.6M
$16.7M
Q1 25
$-24.7M
$13.6M
Q4 24
$-18.9M
$13.7M
Q3 24
$-21.0M
$12.8M
Q2 24
$-25.6M
$10.8M
Gross Margin
PRCT
PRCT
TCBX
TCBX
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
TCBX
TCBX
Q1 26
-4.1%
Q4 25
-40.6%
38.1%
Q3 25
-27.8%
41.9%
Q2 25
-28.0%
40.5%
Q1 25
-39.7%
37.8%
Q4 24
-28.9%
38.7%
Q3 24
-38.4%
37.9%
Q2 24
-50.3%
34.1%
Net Margin
PRCT
PRCT
TCBX
TCBX
Q1 26
-38.1%
28.4%
Q4 25
-39.1%
31.7%
Q3 25
-25.7%
33.1%
Q2 25
-24.7%
32.2%
Q1 25
-35.8%
29.6%
Q4 24
-27.6%
29.7%
Q3 24
-35.9%
29.8%
Q2 24
-48.0%
25.9%
EPS (diluted)
PRCT
PRCT
TCBX
TCBX
Q1 26
$-0.56
$0.88
Q4 25
$-0.54
$1.02
Q3 25
$-0.38
$1.03
Q2 25
$-0.35
$0.96
Q1 25
$-0.45
$0.78
Q4 24
$-0.34
$0.80
Q3 24
$-0.40
$0.74
Q2 24
$-0.50
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TCBX
TCBX
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$650.5M
Total Assets
$487.1M
$6.6B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TCBX
TCBX
Q1 26
$245.6M
Q4 25
$286.5M
$175.2M
Q3 25
$294.3M
$116.4M
Q2 25
$302.7M
$113.1M
Q1 25
$316.2M
$219.0M
Q4 24
$333.7M
$371.2M
Q3 24
$196.8M
$258.2M
Q2 24
$214.1M
$241.8M
Total Debt
PRCT
PRCT
TCBX
TCBX
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TCBX
TCBX
Q1 26
$347.7M
$650.5M
Q4 25
$365.9M
$531.0M
Q3 25
$380.3M
$513.8M
Q2 25
$385.8M
$496.1M
Q1 25
$389.2M
$479.8M
Q4 24
$402.2M
$460.7M
Q3 24
$241.2M
$450.5M
Q2 24
$251.8M
$435.0M
Total Assets
PRCT
PRCT
TCBX
TCBX
Q1 26
$487.1M
$6.6B
Q4 25
$508.1M
$5.3B
Q3 25
$511.5M
$5.1B
Q2 25
$513.1M
$4.9B
Q1 25
$519.4M
$4.9B
Q4 24
$534.0M
$4.9B
Q3 24
$374.1M
$4.6B
Q2 24
$374.4M
$4.5B
Debt / Equity
PRCT
PRCT
TCBX
TCBX
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TCBX
TCBX

Net Interest Income$53.6M93%
Noninterest Income$4.0M7%

Related Comparisons